Atropine sulfate for myopia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Oct 2018: Trial registered, NCT03690089
  2. 3 Apr 2019: Trial started, NCT03690089

The trials

NCT03690089: Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom

State
Under way
Phase
Phase 2
People
289 planned
Started
3 Apr 2019
Primary completion
29 Feb 2024
Arms
Intervention Group (Atropine 0.01%)
Results
None posted
  1. 1 Oct 2018: Trial registered
  2. 3 Apr 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Atropisol, Atropt, Isopto atropine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.